nafamostat has been researched along with E coli Infections in 1 studies
nafamostat: inhibitor of trypsin, plasmin, pancreatic kallikrein, plasma kallikrein & thrombin; strongly inhibits esterolytic activities of C1r & C1 esterase complement-mediated hemolysis; antineoplastic
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Isogai, E | 1 |
| Isogai, H | 1 |
| Kimura, K | 1 |
| Hayashi, S | 1 |
| Kubota, T | 1 |
| Fujii, N | 1 |
| Takeshi, K | 1 |
1 other study available for nafamostat and E coli Infections
| Article | Year |
|---|---|
Role of tumor necrosis factor alpha in gnotobiotic mice infected with an Escherichia coli O157:H7 strain.
Topics: Animals; Bacterial Toxins; Benzamidines; Brain; Colon; Colony Count, Microbial; Edema; Escherichia c | 1998 |